SynthesisPeerJ2024

Efficacy and safety of Brolucizumab for neovascular age-related macular degeneration: a systematic review and meta-analysis.

Ran Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.